LeMaitre Vascular Inc logo

LMAT - LeMaitre Vascular Inc Share Price

$26.35 0.2  0.7%

Last Trade - 3:01pm

Mid Cap
Market Cap £420.8m
Enterprise Value £396.4m
Revenue £95.0m
Position in Universe 2800th / 6327
Unlock LMAT Revenue
Relative Strength (%)
1m +2.51%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -32.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
71.1 78.4 89.2 100.9 105.6 117.2 95.7 115.8 +10.5%
+26.9 +59.2 +34.2 +52.2 -2.0 +7.5 -48.8 +72.6
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2020, LeMaitre Vascular Inc revenues increased 7% to $30.6M. Net income decreased 10% to $3.2M. Revenues reflect United States segment increase of 15% to $17M, Germany segment increase of 7% to $3.3M. Net income was offset by Research and development - increase of 35% to $2.9M (expense), Amortization in SGA increase of 50% to $834K (expense). Dividend per share increased from $0.07 to $0.09.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


LMAT Revenue Unlock LMAT Revenue

Net Income

LMAT Net Income Unlock LMAT Revenue

Normalised EPS

LMAT Normalised EPS Unlock LMAT Revenue

PE Ratio Range

LMAT PE Ratio Range Unlock LMAT Revenue

Dividend Yield Range

LMAT Dividend Yield Range Unlock LMAT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LMAT EPS Forecasts Unlock LMAT Revenue
Profile Summary

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated June 15, 1998
Public Since October 19, 2006
No. of Shareholders: 167
No. of Employees: 454
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Market
Shares in Issue 20,181,698
Free Float (0.0%)
Eligible for
LMAT Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for LMAT
Upcoming Events for LMAT
Thursday 23rd July, 2020
Q2 2020 LeMaitre Vascular Inc Earnings Release
Thursday 23rd July, 2020
Q2 2020 LeMaitre Vascular Inc Earnings Call
Frequently Asked Questions for LeMaitre Vascular Inc
What is the LeMaitre Vascular Inc share price?

As of 3:01pm, shares in LeMaitre Vascular Inc are trading at $26.35, giving the company a market capitalisation of £420.8m. This share price information is delayed by 15 minutes.

How has the LeMaitre Vascular Inc share price performed this year?

Shares in LeMaitre Vascular Inc are currently trading at $26.35 and the price has moved by -10.28% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the LeMaitre Vascular Inc price has moved by -15.09% over the past year.

What are the analyst and broker recommendations for LeMaitre Vascular Inc?

Of the analysts with advisory recommendations for LeMaitre Vascular Inc, there are there are currently 2 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for LeMaitre Vascular Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will LeMaitre Vascular Inc next release its financial results?

LeMaitre Vascular Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the LeMaitre Vascular Inc dividend yield?

The LeMaitre Vascular Inc dividend yield is 1.3% based on the trailing twelve month period.

Does LeMaitre Vascular Inc pay a dividend?

Last year, LeMaitre Vascular Inc paid a total dividend of 0.34, and it currently has a trailing dividend yield of 1.3%. Looking ahead, LeMaitre Vascular Inc has not announced an ex-dividend date yet.

When does LeMaitre Vascular Inc next pay dividends?

LeMaitre Vascular Inc has yet to annouce their ex-dividend date. The historic dividend yield on LeMaitre Vascular Inc shares is currently 1.3%.

How do I buy LeMaitre Vascular Inc shares?

To buy shares in LeMaitre Vascular Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of LeMaitre Vascular Inc?

Shares in LeMaitre Vascular Inc are currently trading at $26.35, giving the company a market capitalisation of £420.8m.

Where are LeMaitre Vascular Inc shares listed? Where are LeMaitre Vascular Inc shares listed?

Here are the trading details for LeMaitre Vascular Inc:

Country of listing: United States
Exchange: NMQ
Ticker Symbol: LMAT
What kind of share is LeMaitre Vascular Inc?

Based on an overall assessment of its quality, value and momentum, LeMaitre Vascular Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a LeMaitre Vascular Inc share price forecast 2020?

Shares in LeMaitre Vascular Inc are currently priced at $26.35. At that level they are trading at 14.64% discount to the analyst consensus target price of 0.00.

Analysts covering LeMaitre Vascular Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.452 for the next financial year.

How can I tell whether the LeMaitre Vascular Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like LeMaitre Vascular Inc. Over the past six months, the relative strength of its shares against the market has been -27.52%. At the current price of $26.35, shares in LeMaitre Vascular Inc are trading at -13.93% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the LeMaitre Vascular Inc PE Ratio?

The LeMaitre Vascular Inc PE ratio based on its reported earnings over the past 12 months is 30.31. The shares are currently trading at $26.35.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of LeMaitre Vascular Inc?

LeMaitre Vascular Inc's management team is headed by:

George LeMaitre - CHM
David Roberts - PRE
Trent Kamke - SVP
Joseph Pellegrino - CFO
Lawrence Jasinski - IND
John O'Connor - IND
Kimberly Cieslak - VPR
Andrew Hodgkinson - SVP
Giovannella Deiure - VPR
John Roush - IND
Laurie Churchill - SVP
Chance Kriesel - VPR
Stephane Maier - VOP
Bridget Ross - IND
Who are the major shareholders of LeMaitre Vascular Inc?

Here are the top five shareholders of LeMaitre Vascular Inc based on the size of their shareholding:

LeMaitre (George W) Individual Investor
Percentage owned: 15.21% (3.07m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 11.78% (2.38m shares)
Conestoga Capital Advisors, LLC Investment Advisor
Percentage owned: 8.53% (1.72m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 6.56% (1.32m shares)
Conestoga Small Cap Fund Mutual Fund
Percentage owned: 5.99% (1.21m shares)
Similar to LMAT
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.